ANI Pharmaceuticals IncNASDAQ:ANIP
- LAST PRICE57.2300
- TODAY'S CHANGE (%)-2.1600 (-3.6370%)
- Bid / Lots54.0700/ 1
- Ask / Lots59.1800/ 1
- Open / Previous Close59.3300 / 59.3900
- Day Range
- 52 Week Range
- Volume224,908
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ANIP |
|---|---|---|
| 09:32 ET | 1557 | 58.94 |
| 09:33 ET | 400 | 58.765 |
| 09:42 ET | 600 | 58.41 |
| 09:44 ET | 754 | 58.45 |
| 09:46 ET | 200 | 58.43 |
| 09:48 ET | 100 | 58.685 |
| 09:50 ET | 401 | 58.355 |
| 09:51 ET | 489 | 58.635 |
| 09:53 ET | 400 | 58.395 |
| 09:57 ET | 1100 | 57.835 |
| 10:02 ET | 100 | 57.645 |
| 10:06 ET | 500 | 58.035 |
| 10:08 ET | 700 | 58.175 |
| 10:15 ET | 764 | 58.73 |
| 10:22 ET | 172 | 58.33 |
| 10:24 ET | 3200 | 58.055 |
| 10:26 ET | 1455 | 58.26 |
| 10:27 ET | 400 | 58.215 |
| 10:29 ET | 600 | 58.045 |
| 10:31 ET | 500 | 58.17 |
| 10:33 ET | 1004 | 58.05 |
| 10:36 ET | 1834 | 57.825 |
| 10:38 ET | 2186 | 57.765 |
| 10:44 ET | 400 | 57.44 |
| 10:45 ET | 700 | 57.515 |
| 10:47 ET | 900 | 57.59 |
| 10:49 ET | 449 | 57.75 |
| 10:51 ET | 100 | 57.9 |
| 11:02 ET | 500 | 57.74 |
| 11:05 ET | 400 | 57.67 |
| 11:07 ET | 100 | 57.67 |
| 11:14 ET | 943 | 57.94 |
| 11:20 ET | 300 | 58.24 |
| 11:21 ET | 712 | 58.02 |
| 11:23 ET | 1871 | 57.83 |
| 11:39 ET | 800 | 57.87 |
| 11:41 ET | 1851 | 57.615 |
| 11:43 ET | 400 | 57.77 |
| 11:45 ET | 1132 | 57.79 |
| 11:48 ET | 500 | 57.89 |
| 11:50 ET | 332 | 57.62 |
| 11:52 ET | 1905 | 57.415 |
| 11:54 ET | 1701 | 57.2225 |
| 11:59 ET | 300 | 57.06 |
| 12:01 ET | 1526 | 57.03 |
| 12:03 ET | 700 | 56.89 |
| 12:06 ET | 3026 | 57.195 |
| 12:08 ET | 400 | 57.11 |
| 12:12 ET | 826 | 57.26 |
| 12:14 ET | 1575 | 57.1 |
| 12:15 ET | 100 | 56.97 |
| 12:17 ET | 100 | 56.935 |
| 12:19 ET | 100 | 57.08 |
| 12:21 ET | 875 | 56.77 |
| 12:24 ET | 6585 | 57.035 |
| 12:26 ET | 100 | 57.02 |
| 12:28 ET | 100 | 57.02 |
| 12:30 ET | 1679 | 57.185 |
| 12:35 ET | 510 | 57.14 |
| 12:37 ET | 819 | 57.01 |
| 12:39 ET | 1200 | 57.08 |
| 12:42 ET | 4600 | 56.985 |
| 12:44 ET | 1310 | 57.085 |
| 12:46 ET | 400 | 57.05 |
| 12:48 ET | 400 | 57.05 |
| 12:50 ET | 100 | 57.05 |
| 12:51 ET | 4546 | 57.085 |
| 12:53 ET | 1528 | 56.995 |
| 12:55 ET | 6061 | 57.28 |
| 12:57 ET | 1100 | 57.46 |
| 01:00 ET | 57455 | 57.23 |
Nov 26, 2024
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference, from 4:30PM ET on Tuesday Nov 26, 2024 by Dow Jones
4:30PM ET on Tuesday Nov 26, 2024 by Dow Jones
Nov 11, 2024
DJ ANI Pharmaceuticals Price Target Maintained With a $94.00/Share by HC Wainwright & Co., from 10:32AM ET on Monday Nov 11, 2024 by Dow Jones
10:32AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 8, 2024
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance, from 6:50AM ET on Friday Nov 08, 2024 by Dow Jones
6:50AM ET on Friday Nov 08, 2024 by Dow Jones*DJ ANI Pharmaceuticals 3Q Loss/Shr $1.27 >ANIP, from 6:50AM ET on Friday Nov 08, 2024 by Dow Jones
6:50AM ET on Friday Nov 08, 2024 by Dow Jones
Nov 4, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ANI Pharmaceuticals Inc | 1.2B | -127.5x | -8.16% |
Collegium Pharmaceutical Inc | 1.0B | 15.3x | --- |
Innoviva Inc | 1.2B | 27.6x | -8.76% |
SNDL Inc | 520.4M | -6.4x | --- |
Harmony Biosciences Holdings Inc | 2.0B | 16.4x | --- |
Procaps Group SA | 235.8M | 2.9x | --- |
Company Information
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel, as well as its generics business with enhanced research and development capabilities. Its three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, and one is located in East Windsor, New Jersey, are together capable of producing oral solid dose products, as well as semi-solids, liquids and topicals, controlled substances, and potent products. The Company has a commercial portfolio of approximately 118 products with a variety of indications and a robust portfolio of pipeline products.
Contact Information
- Headquarters
- 210 Main Street WestBAUDETTE, MN, United States 56623
- Phone
- 218-634-3500
- Fax
- 218-634-3540
Executives
- Interim President, Chief Executive Officer, Director
- Patrick Walsh
- President, Chief Executive Officer, Director
- Nikhil Lalwani
- Chief Financial Officer, Senior Vice President
- Stephen Carey
- Chief Human Resource Officer, Senior Vice President
- Krista Davis
- Senior Vice President, General Counsel, Corporate Secretary
- Meredith Cook
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $555.5M |
Shares Outstanding | 21.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.74 |
EPS | $-0.45 |
Book Value | $22.35 |
P/E Ratio | -127.5x |
Price/Sales (TTM) | 2.2 |
Price/Cash Flow (TTM) | 24.2x |
Operating Margin | 0.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
